Clinical Selection Test: Content, design and how we will use it
In response to the impacts of Covid-19 on clinical programme entry for 2023, the Faculty of Medical and Health Sciences has re-introduced a Clinical Selection Test (CST).
Who has to sit the CST?
All students enrolled in CHEM 110, BIOSCI 107 or POPLHLTH 111 in Semester One 2022 who are intending to apply for any of the following FMHS undergraduate clinical programmes for 2023 commencement under the following entry categories:
- Bachelor of Medicine and Bachelor of Surgery - MBChB: First Year Entry
- Bachelor of Pharmacy - BPharm: First Year Entry
- Bachelor of Pharmacy – BPharm: Alternative Admissions*
- Bachelor of Optometry - BOptom: Undergraduate Entry*
- Bachelor of Medical Imaging (Honours) - BMedImag (Hons): Undergraduate Entry*
*including those students in their second year of study who are completing some or all of the CST courses in Semester One 2022.
Who does NOT have to sit the CST?
- MBChB - Graduate applicants
- MBChB – Undergraduate applicants with conditional offers/International Pathway students
- MBChB - Graduate applicants with conditional offers
- Optometry - Graduate applicants
- Medical Imaging (Hons) - Graduate applicants
- Pharmacy - Alternative Admissions applicants**
Please contact Student Hubs if you are unclear about your individual situation.
** including those applicants who are not sitting any of the CST courses in Semester One 2022
How will CST be used for MMI and programme selection for First Year/Undergraduate applicants?
The Clinical Programmes each have an ‘Eligibility’ GPA requirement. The CST will not be used for ‘Eligibility’. We will use your official ‘Semester Grade’ for this.
For MMI invitation and Final Offers, the CST will be weighted against the respective core courses (from Semester One) only. The weighting of this is 60% CST:40% semester grade GPA.